Topics

Eureka Therapeutics, Inc. Company Profile

15:24 EDT 19th September 2019 | BioPortfolio

Eureka Therapeutics, Inc. is a privately held biotechnology company, headquartered in the San Francisco Bay area, focused on developing first-in-class T cell immunotherapies for hematological malignancies and solid tumors. Its core technology platforms center around the discovery and engineering of fully human antibodies against intracellular targets via the MHCI complex. The company is developing a pipeline of novel cancer therapeutics targeting intracellular oncogenes.


News Articles [919 Associated News Articles listed on BioPortfolio]

Eureka Therapeutics Starts US Trial of Liver Cancer T-Cell Therapy

Eureka Therapeutics, a Bay Area immunotherapy company, began a US Phase I/II clinical trial of its liver cancer T-Cell therapy at the City of Hope Hospital in Los Angeles. Last year, the candidate com...

Eureka Therapeutics Announces Initiation of Phase 1/2 Clinical Trial of ET140202 ARTEMIS™ T-Cell Therapy in Liver Cancer

- Potential to Accelerate Application of T-Cell Therapy to Other Solid Tumors Eureka Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel T-cell therapies that harness the...

Eureka Therapeutics Announces Publication of Preclinical Study Demonstrating GPRC5D as a Promising Target for Antibody-Based Therapies in Multiple Myeloma

Potential to target GPRC5D in multiple myeloma patients relapsed after BCMA-targeted therapy Eureka Therapeutics, Inc., a clinical stage biotechnology...

Eureka Therapeutics Announces Publication of Preclinical Study Demonstrating Selective Depletion of Tregs Using Foxp3 Targeting TCR-mimic Antibody

Potential to Improve Efficacy of T-cell and Immune Checkpoint Blockade Therapies in Solid Tumors Eureka Therapeutics, Inc., a clinical stage biotechno...

Can a Play About Vaccines Be a Laughing Matter?

At the privileged private school in “Eureka Day,” some parents refuse to give shots to their children. Then the mumps hits.

North Bud Farms Signs Binding Letter of Intent to Enter U.S. Market with Strategic Acquisition of Multi-State Licensed Operator Eureka Vapor

TORONTO, March 06, 2019 (GLOBE NEWSWIRE) -- North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) ("NORTHBUD" or the "Company") is pleased to announce that effective March 3, 2019 it entered into a bind...

Eureka! America's No. 1 Edibles Brand Poised to Enter California

Desert Hot Springs, Calif. - July 10, 2019 (Investorideas.com Newswire) The wait is (almost) over! Wana Brands is bringing its top-selling, all-natural line of cannabis infused products to California ...

Combine AI With Crowdsourcing and What Do You Get? Turbocharged Innovation

A great analogy can often be the key to innovation, making it possible to transfer knowledge from one domain to another. Now researchers have shown that rather than relying on eureka moments, crowdsou...

PubMed Articles [444 Associated PubMed Articles listed on BioPortfolio]

Effect of the desiccation tolerance and cryopreservation methods on the viability of Citrus limon L. Burm cv. Eureka seeds.

Cryopreservation of the germplasm for long-term periods is of great importance to maintain the genetic resource. Argentina is one of the world's highest lemon producing country. The performance of dif...

Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.

There is mounting evidence supporting the use of biologic therapeutics for the management of noninfectious uveitis (NIU). This review highlights: biologics with documented efficacy in NIU; agents with...

CRISPR: a promising tool for lipid physiology and therapeutics.

The purpose is to review recent progress in applying the CRISPR/Cas9 system to lipid metabolism and therapeutics.

Advancing Nucleic Acid Therapeutics by Setting Uniform Standards for Experimental Controls.

Antiglaucoma EP Agonists: A Long Road That Led Somewhere.

For >2 decades, EP agonists have been the subject of antiglaucoma research and development by scientists in industry and academia around the world. The road has led to the recent approval of the first...

Clinical Trials [192 Associated Clinical Trials listed on BioPortfolio]

Clinical Investigation to Assess the Performance of the Eureka Electric Breast Pump in Mothers Breastfeeding Their Healthy Term Infant

Babies are the best in class in order to get human milk out of a lactating breast. With this in mind, Philips has developed the a new electric breast pump, attempting to mimic the babies s...

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

The purpose of the study is to assess long-term side effects from subjects who receive a Fate Therapeutics genetically modified NK cell product. Subjects who previously took part in a Fate...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

Companies [1378 Associated Companies listed on BioPortfolio]

Eureka Therapeutics Inc.

Eureka Therapeutics Inc. is a privately held biotechnology company, headquartered in the San Francisco Bay area, focused on developing first-in-class T cell immunotherapies for he...

Eureka Therapeutics, Inc.

Eureka Therapeutics, Inc. is a privately held biotechnology company, headquartered in the San Francisco Bay area, focused on developing first-in-class T cell immunotherapies for h...

Eureka Casino Resort

The Eureka Casino Resort is an intimate, newly renovated, 214-room resort located in Mesquite, Nevada, 35 miles south of St. George, Utah. The hotel recently renovated each guest room, and built a res...

Eureka Genomics

Eureka Genomics is a privately held company and a leader in the advanced bioinformatics analysis of next-generation sequencing data. The company applies its capabilities to the di...

Eureka Science

Eureka Science offers creative solutions to a large variety of publishing and related activities which may be purely online or of a more traditional hard copy variety. In addition, we also offer a w...

More Information about "Eureka Therapeutics, Inc." on BioPortfolio

We have published hundreds of Eureka Therapeutics, Inc. news stories on BioPortfolio along with dozens of Eureka Therapeutics, Inc. Clinical Trials and PubMed Articles about Eureka Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Eureka Therapeutics, Inc. Companies in our database. You can also find out about relevant Eureka Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...


Corporate Database Quicklinks



Searches Linking to this Company Record